Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$16.93 - $26.82 $1.51 Million - $2.4 Million
-89,400 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$21.86 - $34.77 $1.95 Million - $3.11 Million
89,400 New
89,400 $2.34 Million

Others Institutions Holding RLMD

About RELMADA THERAPEUTICS, INC.


  • Ticker RLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,608,500
  • Market Cap $10.9M
  • Description
  • Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...
More about RLMD
Track This Portfolio

Track Healthcare Of Ontario Pension Plan Trust Fund Portfolio

Follow Healthcare Of Ontario Pension Plan Trust Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.